GAMBARAN KLINIKOPATOLOGI KARSINOMA PAYUDARA DI RSUP DR. M. DJAMIL PADANG TAHUN 2023

Muhammad Rifki; Nana Liana; Irwan Triansyah; Roland  Helmizar; Lismawati Lismawati; Desi Aliefia; Muhammad Rizki Saputra; Ruhsyahadati Ruhsyahadati; Rahma Triyana

doi:10.59003/nhj.v5i12.2046

Authors

Muhammad Rifki Universitas Baiturrahmah
Nana Liana Universitas Baiturrahmah
Irwan Triansyah Universitas Baiturrahmah
Roland Helmizar Universitas Baiturrahmah
Lismawati Lismawati Universitas Baiturrahmah
Desi Aliefia Universitas Baiturrahmah
Muhammad Rizki Saputra Universitas Baiturrahmah
Ruhsyahadati Ruhsyahadati Universitas Baiturrahmah
Rahma Triyana Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v5i12.2046

Keywords:

Breast Cancer, Histopathology Subtype, Grading, Lymphovascular Invasion, Molecular Subtype

Abstract

Background: Breast cancer is a malignancy originating from epithelial cells of the breast ducts or lobules. Clinicopathological characteristics are important in determining prognosis and treatment. Understanding these features is essential to support early detection and improve management strategies. Objective: This study aimed to describe the clinicopathological features of breast cancer patients at RSUP Dr. M. Djamil Padang in 2023. Methods: This descriptive observational study used a cross-sectional design with secondary data. A total of 114 samples were collected using the total sampling technique. Data were analyzed using univariate analysis with Statistical Product and Service Solution (SPSS) version 25. Results: Among 114 breast cancer patients, the most common age group was 35–44 years, accounting for 37 patients (32.5%). The predominant histopathological subtype was Mixed Infiltrating Duct NST with Lobular Carcinoma in 37 patients (32.5%). Histopathological grading was most commonly grade 2 in 79 patients (69.3%). Positive lymphovascular invasion was identified in 76 patients (66.7%). The most frequent molecular subtype was Luminal B, found in 51 patients (44.7%). Conclusion: Breast cancer was most prevalent in patients aged 35–44 years. The dominant histopathological subtype was Mixed Infiltrating Duct NST with Lobular Carcinoma, with grade 2 and positive lymphovascular invasion most frequently observed. Luminal B was the predominant molecular subtype. Increasing awareness of early detection through breast self-examination is recommended.

Downloads

Download data is not yet available.

References

Angahar LT. An Overview of Breast Cancer Epidemiology, Risk Factors, Pathophysiology, and Cancer Risks Reduction. MOJ Biology and Medicine. 10 Juli 2017;1(4).

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, dkk. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. Mei 2024;74(3):229–63.

Statistics at a glance, 2022 Top 5 most frequent cancers Number of new cases 408 661 Number of deaths 242 988 Number of prevalent cases (5-year) [Internet]. [dikutip 24 Oktober 2024]. Tersedia pada:

https://gco.iarc.who.int/media/globocan/factshe ets/populations/360-indonesia-fact-sheet.pdf

Kementerian Kesehatan Republik Indonesia. Hari Kanker Sedunia 2019 [Internet]. 2019

[dikutip 6 Oktober 2024]. Tersedia pada: https://www.kemkes.go.id/id/rilis- kesehatan/hari-kanker-sedunia- 2019#:~:text=Hari%20Kanker%20Sedunia%20 diperingati%20setiap,mengurangi%20beban%2 0akibat%20penyakit%20kanker.

Putri SA, Asri A, Ellianti A, Khambri D. Karakteristik Klinikopatologi Karsinoma Payudara Invasif di RSUP M. Djamil Padang Periode 2018-2019. [Padang]: Fakultas Kedokteran, Universitas Andalas; 2022.

Suarfi A, Anggraini D, Nurwiyeni. Gambaran Histopatologi Tumor Ganas Payudara Di Laboratorium Patologi Anatomi RSUP M. Djamil Padang Tahun 2017. [Padang]: Fakultas Kedokteran, Universitas Baiturrahmah; 2019.

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer— epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Vol. 13, Cancers. MDPI; 2021.

Lokuhetty D, White VA, Watanabe R, Cree IA. Breast Cancer . 5th ed. Lyon: International Agency for Research on Cancer ; 2019.

Höller A, Nguyen-Sträuli BD, Frauchiger- Heuer H, Ring A. Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now? Vol. 15, Breast Cancer: Targets and Therapy. Dove Medical Press Ltd; 2023. hlm. 525–40.

Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LFA, dkk. Refinement of breast cancer classification by molecular characterization of histological special types. Journal of Pathology. Oktober 2008;216(2):141–50.

Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. Ki-67 as a prognostic biomarker in invasive breast cancer. Vol. 13, Cancers. MDPI; 2021.

Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S. Updates on Lymphovascular Invasion in Breast Cancer. Vol. 11, Biomedicines. MDPI; 2023.

Firdaus VPR, Asri A, Khambri D, Harahap WA. Hubungan Grading Histopatologi dan Infiltrasi Limfovaskular dengan Subtipe Molekuler pada Kanker Payudara Invasif di Bagian Bedah RSUP. Dr. M. Djamil Padang. Vol. 5, Jurnal Kesehatan Andalas. 2016.

Kementerian Kesehatan RI (2018). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Payudara [Internet]. Jakarta : Kementerian Kesehatan RI; 2018 [dikutip 6 Oktober 2024]. Tersedia pada: https://www.kemkes.go.id/id/pnpk-2018---tata- laksana-kanker-payudara

Fregene A, Newman LA. Breast cancer in sub- Saharan Africa: How does it relate to breast cancer in African-American women? Vol. 103, Cancer. 2015. hlm. 1540–50.

Premenopausal Breast Cancer Collaborative Group. Premenopausal breast cancer: A review of the evidence and a call for action. Breast Cancer Res. 2017;19(1):1–9.

Metzger-Filho O, Ferreira AR, Jeselsohn R, Barry WT, Dillon DA, Brock JE, dkk. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade. Oncologist. 1 Juli 2019;24(7):e441–9.

Arps DP, Healy P, Zhao L, Kleer CG, Pang JC. Invasive ductal carcinoma with lobular features: A comparison study to invasive ductal and invasive lobular carcinomas of the breast. Breast Cancer Res Treat. April 2015;138(3):719–26.

Xiao Y, Ma D, Ruan M, Zhao S, Liu XY, Jiang YZ, dkk. Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status. Sci Rep. 1 Desember 2017;7(1).

Subiyanto D, Kadi TA, Ismaiyah I, Abdurrahman N, Utomo YP, Alifiansyah AR, dkk. Subtipe Molekuler Kanker Payudara di RSUD Madiun dan Hubungannya dengan Grading Histopatologi. Media Penelitian dan Pengembangan Kesehatan. 13 Desember 2021;31(3):193–202.

Setyorini G, Sasmithae L, Fianza PI, Kurnia D. Hubungan subtipe molekuler kanker payudara dengan grading histopatologi di RSUD M Yunus Bengkulu. Intisari Sains Medis. 26 Juni 2023;14(2):519–24.

Mota AM, Mendes J, Matela N. Breast Cancer Molecular Subtype Prediction: A Mammography-Based AI Approach. Biomedicines. 1 Juni 2024;12(6).

Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA. Subtypes of Breast Cancer. Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, FL, USA and

H.N. Mayrovitz (eds) Breast Cancer: Exon Publications; 2022. 31–42 hlm.

Shah OS, Nasrazadani A, Foldi J, Atkinson JM, Kleer CG, McAuliffe PF, dkk. Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proc Natl Acad Sci U S A. 30 Juli 2024;121(31).

Permatasari LI, Djafar NH, Toka W Do. Analisis Penderita Kanker Payudara di RSUD Dr. H. Chasan Boesoirie Kota Ternate. MAHESA : Malahayati Health Student Journal. 1 Januari 2024;4(1):187–92.

Khaerunnisa AB, Latief S, Syahruddin FI, Royani I, Juhamran RP. Hubungan Tingkat Pengetahuan dan Sikap terhadap Deteksi Dini Kanker Payudara pada Pegawai Rumah Sakit Ibnu Sina Makassar. FAKUMI MEDICAL JOURNAL. 2023;3(9):685–94.

Gelgel Janaari Pramana Putri, Christian INW Steven. Karakteristik Kanker Payudara Wanita di Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2014-2015. JURNAL MEDIKA UDAYANA. 2020;9(3):52–7.

Suganda A, Wiratmoko W, Marhayuni E. Grading Grade 3 Grade 2 Grade 1 Total Frekuensi. Medika Malahayati. 2021;5(2):77– 82.

Hasfira FI, Oktaviyanti IK, Budiwinata W, Priyono SH, Rosida L. Hubungan Usia Dengan Derajat Diferensiasi Kanker Payudara Pada Wanita. Homeostasis. Agustus 2024;7(2):357– 66.

Afarel AR, Hardiyanto H, Anwar SLA. Hubungan Ki-67, Lymphovascular Invasion (LVI), dan Status Limfonodi terhadap Disease- Free Survival pada Pasien Kanker Payudara di RSUP Dr. Sardjito. [Yogyakarta]: Universitas Gadjah Mada; 2023.

D’abreo N, Rohatgi A, Marks DK, Kling HM, Haan J, Audeh W. Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer. J Breast Cancer. 2017.

Yu J, da Silva EM, La HS, Clark BZ, Fine JL, Carter GJ, dkk. Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity? NPJ Breast Cancer. 1 Desember 2023;9(1).